ArticleOncoimmunology2022

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody.

Jessica D Weaver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.